Evidence map›Paper›PMID 23824501›Full record

ArticleNeurotoxicity research2013

Role of PGE₂ EP1 receptor in intracerebral hemorrhage-induced brain injury.

Nilendra Singh, Bo Ma, Christopher Charles Leonardo, Abdullah Shafique Ahmad, Shuh Narumiya, Sylvain Doré

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicity research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Genetic Deletion of PGFFrontiers in neuroscience · 2018
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Nilendra SinghDepartment of Anesthesiology, Center for Translational Research in Neurodegenerative Disease, University of Florida, 1275 Center Drive, Biomed Sci J493, PO Box 100159, Gainesville, FL, 32610-0159, USA.
Bo Ma
Christopher Charles Leonardo
Abdullah Shafique Ahmad
Shuh Narumiya
Sylvain Doré
University of Florida · USKyoto University · JPNational Institute on Aging · US

Funding

Role of Prostaglandin Receptors in StrokeR01NS046400 · NINDS · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2003 to 2014
$3.0M
PG receptors in controling excitotoxicity in aging brainR01AG022971 · NIA · JOHNS HOPKINS UNIVERSITY · PI DORE, SYLVAIN · 2004 to 2008
$1.6M
NIA NIH HHS AG022971NIA NIH HHS R01 AG022971NINDS NIH HHS NS046400NINDS NIH HHS R01 NS046400
6 · The paper itself

Abstract

Prostaglandin E₂ (PGE₂) has been described to exert beneficial and detrimental effects in various neurologic disorders. These conflicting roles of PGE₂ could be attributed to its diverse receptor subtypes, EP1-EP4. At present, the precise role of EP1 in intracerebral hemorrhage (ICH) is unknown. Therefore, to elucidate its possible role in ICH, intrastriatal injection of collagenase was given in randomized groups of adult male wildtype (WT) and EP1 receptor knockout (EP1⁻/⁻)C57BL/6 mice. Functional outcomes including neurologic deficits, rotarod performance, open field activity, and adhesive removal performance were evaluated at 24, 48, and 72 h post-ICH. Lesion volume, cell survival and death, were assessed using Cresyl Violet, and Fluoro-Jade staining, respectively. Microglial activation and phagocytosis were estimated using Iba1 immunoreactivity and fluorescently-labeled microspheres. Following 72 h post-ICH, EP1⁻/⁻ mice showed deteriorated outcomes compared to the WT control mice. These outcomes were demonstrated by elevated neurological deficits, exacerbated lesion volume, and significantly worsened sensorimotor functions. Fluoro-Jade staining showed significantly increased numbers of degenerating neurons and reduced neuronal survival in EP1⁻/⁻ compared to WT mice. To assess in vivo phagocytosis, the number of microspheres phagocytosed by Iba1-positive cells was 145.4 ± 15.4 % greater in WT compared to EP1⁻/⁻ mice. These data demonstrate that EP1 deletion exacerbates neuro-behavioral impairments following ICH, potentially by slowing down/impairing microglial phagocytosis. A better understanding of this EP1 mechanism could lead to improved intervention strategies for hemorrhagic stroke.

Indexed as

AnimalsBrain InjuriesCell DeathCerebral HemorrhageCorpus StriatumMaleMiceMice, Inbred C57BLMice, KnockoutMicrogliaPhagocytosisReceptors, Prostaglandin E, EP1 SubtypeReceptors, Prostaglandin E, EP1 Subtype

Identifiers

PMID23824501
PMCPMC3788039
OpenAlexW1965853984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.